Norway’s $1.3 Trillion Fund May Be Facing a Major ESG Handicap (Bloomberg)
Norway’s $1.3 trillion wealth fund, the world’s biggest, is handicapped in chasing its environmental, social and governance investment goals by the political process, according to Global SWF. The lengthy decision-making that determines which asset classes Norway’s investing behemoth can buy puts it at a disadvantage compared with smaller money managers, “in particular” regarding ESG, according to Diego Lopez, a managing director at the independent group. Global SWF provides data and analysis on more than 400 sovereign investors and public pension funds.
Arlington Capital Partners Announces Strategic Minority Investment by Goldman Sachs Asset Management (Businesswire.com)
WASHINGTON–(BUSINESS WIRE)–Arlington Capital Partners (“Arlington”), a leading middle market private equity firm, today announced a passive, non-voting, minority equity investment by Goldman Sachs Asset Management’s (“GSAM”) Petershill program, creating a strategic relationship with one of the world’s leading investment managers and accelerating Arlington’s growth and success. The investment follows a multi-decade relationship between Goldman Sachs and Arlington in which GSAM has been a limited partner investor in Arlington’s funds. The transaction will have no impact on the day-to-day operations or management of Arlington.
Monday 2/22 Insider Buying Report: TLIS, SONA (Nasdaq.com)
At Talis Biomedical, a filing with the SEC revealed that on Wednesday, Director Matthew L. Posard bought 62,500 shares of TLIS, at a cost of $16.00 each, for a total investment of $1M. Posard was up about 53.0% on the buy at the high point of today’s trading session, with TLIS trading as high as $24.48 in trading on Monday. Talis Biomedical is trading up about 5.7% on the day Monday. This buy marks the first one filed by Posard in the past year. And also on Wednesday, EVP, CFO Matthew Alan Switzer bought $644,000 worth of Southern National Bancorp Of Virginia, buying 50,000 shares at a cost of $12.88 each. This purchase marks the first one filed by Switzer in the past twelve months. Southern National Bancorp Of Virginia is trading up about 1.7% on the day Monday. So far Switzer is in the green, up about 6.1% on their purchase based on today’s trading high of $13.67.
Insider Trading: February 22, 2021 (BIV.com)
Insider Peter John Bonner, director. Company: Madison Pacific Properties Inc. (TSX:MPC). Shares owned: 653,413. Trade date: February 5. Trade total: $496,830. Trade: Acquisition of 139,559 shares at a price of $3.56 per share. Insider Laurent Mathiot, 10% owner. Company: Orea Mining Corp. (TSX:OREA). Shares owned: 19,334,500. Trade date: February 4, 5, 8. Trade total: $319,750. Trade: Sale of 2,185,000 shares at a price of $0.14 to $0.15 per share.
The Past Week’s Notable Insider Buys: More Biotech IPOs, Bumble, Fiserv And More (Benzinga)
Here are some of the most noteworthy insider purchases that were reported in the past week. Talis Biomedical Corp (TLIS) saw its chief financial officer acquire almost 1,700 shares in its initial public offering, while other insiders bought more than 6.63 million shares altogether. At an offering price of $16.00 per share, the total for all these purchases came to over $106.22 million. Decibel Therapeutics Inc (DBTX) had a 10% owner and two directors buy shares of in its IPO. The more than 2.39 million shares acquired, at $18.00 apiece, totaled nearly $43.05 million. The stock has traded as high as $24.39 so far, but it closed most recently at $19.05 per share.
The Walt Disney Co (DIS) SEVP & Chief Comms Officer Zenia B. Mucha Sold $6.2 million of Shares (Guru Focus)
SEVP & Chief Comms Officer of The Walt Disney Co, Zenia B. Mucha, sold 33,969 shares of DIS on 02/18/2021 at an average price of $183.12 a share. The total sale was $6.2 million. Walt Disney Co together with its subsidiaries is a diversified worldwide entertainment company with operations in four business segments: Media Networks, Parks and Resorts, Studio Entertainment, and Consumer Products & Interactive Media.
The Vice-President of Operations of Empower Clinics (Other OTC: EPWCF) is Selling Shares (Analyst Ratings)
Today, the Vice-President of Operations of Empower Clinics (EPWCF), Andrea Klein, sold shares of EPWCF for $2.54M. In addition to Andrea Klein, 2 other EPWCF executives reported Sell trades in the last month. EPWCF’s market cap is $263 million and the company has a P/E ratio of -35.10. The company has a one-year high of $1.42 and a one-year low of $0.01. The insider sentiment on Empower Clinics has been negative according to 13 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
